Kairos Pharma | Using New Tech to Transform Cancer Treatment

2024/10/17 Talking about cancer is not easy. It’s a sensitive subject that many don’t want to discuss and the mental and physical toll cancer treatment takes on BOTH those diagnosed and those related to the person diagnosed can be very harsh and negative. However, NYSE American-listed Kairos Pharma is out there trying to transform the way cancer is treated. A clinical stage biopharmaceutical company that is transforming the way cancer is treated by using new technologies developed through structural biology. In an MWS exclusive interview, Kairos Pharma CEO John Yu discusses what Kairos Pharma is all about.
Subscribe NOW to Modern Wall Street: http://bit.ly/2wsU9rO

Get more Modern Wall Street:
Like Modern Wall Street: http://Facebook.com/modernwallstreet/
Follow Modern Wall Street: http://Twitter.com/ModernWallSt
Insta Follow: http://Instagram.com/modernwallstreet/